Oral shrimp vaccine gets market launch funding

Quoc Viet was the first shrimp farm to apply for and receive ASC Shrimp Standard certification

A funding round worth US$8.25m will enable the commercial scale-up of an oral vaccine for shrimp

Biotech company, ViAqua Therapeutics, has completed a US$8.25 million funding round to help market its orally-administered vaccine for shrimp.

The company teamed up with S2G Ventures with participation from Rabo Ventures, The Trendlines Group, Agriline Limited, Nutreco, I-Lab Angels and Circle Investments to raise the funds.

Continue this article…

Already subscribed? SIGN IN now


Sign up for FREE to continue this article!

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:

  • Weekly newsletters providing valuable news and information on the commercial fishing and aquaculture sector
  • Full access to our news archive
  • Live and archived webinars, podcasts and videos
  • Articles on innovations and current trends in the commercial fishing industry
  • Our extensive archive of data, research and intelligence

Get more free content sign up today

Ready to subscribe? Choose from one of our subscription packages for unlimited access!